Is Rapamycin a Dietary Restriction Mimetic?
暂无分享,去创建一个
[1] R. Weiss,et al. Induction of fat apoptosis by a non‐thermal device: Mechanism of action of non‐invasive high‐intensity electromagnetic technology in a porcine model , 2018, Lasers in surgery and medicine.
[2] S. Subramanian,et al. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat , 2018, Experimental physiology.
[3] Jie Chen,et al. Effects of rapamycin on growth hormone receptor knockout mice , 2018, Proceedings of the National Academy of Sciences.
[4] Anindita Das,et al. Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury , 2017, British journal of pharmacology.
[5] John J. Cole,et al. Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions , 2017, Genome Biology.
[6] Peter D. Adams,et al. Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment , 2017, Genome Biology.
[7] D. Seals,et al. Dietary rapamycin supplementation reverses age‐related vascular dysfunction and oxidative stress, while modulating nutrient‐sensing, cell cycle, and senescence pathways , 2016, Aging cell.
[8] K. Kim,et al. Caloric Restriction and Rapamycin Differentially Alter Energy Metabolism in Yeast , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.
[9] D. Harrison,et al. Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes , 2016, Aging.
[10] A. Young,et al. Prolonged Calorie Restriction Downregulates Skeletal Muscle mTORC1 Signaling Independent of Dietary Protein Intake and Associated microRNA Expression , 2016, Front. Physiol..
[11] Kathleen F. Kerr,et al. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice , 2016, eLife.
[12] S. A. Arriola Apelo,et al. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.
[13] D. Féliers,et al. Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.
[14] L. Ferrucci,et al. Effects of Sex, Strain, and Energy Intake on Hallmarks of Aging in Mice. , 2016, Cell metabolism.
[15] Dudley Lamming,et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer , 2016, Aging cell.
[16] Dudley Lamming. Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond. , 2016, Cold Spring Harbor perspectives in medicine.
[17] R. Kondratov,et al. Circadian clocks govern calorie restriction—mediated life span extension through BMAL1‐ and IGF‐1‐dependent mechanisms , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] E. Ravussin,et al. Effects of 2‐year calorie restriction on circulating levels of IGF‐1, IGF‐binding proteins and cortisol in nonobese men and women: a randomized clinical trial , 2015, Aging cell.
[19] A. Richardson,et al. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story , 2015, Experimental Gerontology.
[20] P. Rabinovitch,et al. Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice , 2015, Front. Genet..
[21] Yun Li,et al. Effect of caloric restriction on the SIRT1/mTOR signaling pathways in senile mice , 2015, Brain Research Bulletin.
[22] C. Livi,et al. p53 and rapamycin are additive , 2015, Oncotarget.
[23] W. Fok,et al. Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.
[24] Nolan G. Ericson,et al. Subacute calorie restriction and rapamycin discordantly alter mouse liver proteome homeostasis and reverse aging effects , 2015, Aging cell.
[25] B. Phillips-Farfán,et al. Caloric restriction protects against electrical kindling of the amygdala by inhibiting the mTOR signaling pathway , 2015, Front. Cell. Neurosci..
[26] Dudley Lamming,et al. Rapamycin-induced metabolic defects are reversible in both lean and obese mice , 2014, Aging.
[27] C. Livi,et al. Short-term rapamycin treatment in mice has few effects on the transcriptome of white adipose tissue compared to dietary restriction , 2014, Mechanisms of Ageing and Development.
[28] M. Antoch,et al. Metabolic clock generates nutrient anticipation rhythms in mTOR signaling , 2014, Aging.
[29] B. Vollmar,et al. Lifelong caloric restriction reprograms hepatic fat metabolism in mice. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[30] M. Mirisola,et al. Calorie Restriction in Mammals and Simple Model Organisms , 2014, BioMed research international.
[31] Z. D. Sharp,et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction , 2014, Aging cell.
[32] S. Austad,et al. Rapamycin extends life and health in C57BL/6 mice. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[33] W. Wood,et al. Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome , 2014, PloS one.
[34] W. Wood,et al. Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver , 2013, Aging cell.
[35] Yimin Fang,et al. Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice , 2013, eLife.
[36] A. Richardson. Rapamycin, anti-aging, and avoiding the fate of Tithonus. , 2013, The Journal of clinical investigation.
[37] Dudley Lamming,et al. Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive , 2013, Aging cell.
[38] G. Enikolopov,et al. Calorie restriction alleviates the age‐related decrease in neural progenitor cell division in the aging brain , 2013, The European journal of neuroscience.
[39] Nektarios Tavernarakis,et al. Metabolic Control by Target of Rapamycin and Autophagy during Ageing - A Mini-Review , 2013, Gerontology.
[40] Jie Chen,et al. Duration of rapamycin treatment has differential effects on metabolism in mice. , 2013, Cell metabolism.
[41] M. Kaeberlein. Faculty Opinions recommendation of The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. , 2013 .
[42] C. Livi,et al. Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors , 2013, Aging.
[43] P. Rabinovitch,et al. mTOR is a key modulator of ageing and age-related disease , 2013, Nature.
[44] Dean P. Jones,et al. Short-Term Treatment With Rapamycin and Dietary Restriction Have Overlapping and Distinctive Effects in Young Mice , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[45] S. Kliewer,et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice , 2012, eLife.
[46] M. Antoch,et al. Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice , 2012, Aging.
[47] M. Antoch,et al. New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis , 2012, Aging.
[48] T. von Zglinicki,et al. Male mice retain a metabolic memory of improved glucose tolerance induced during adult onset, short-term dietary restriction , 2012, Longevity & healthspan.
[49] C. Selman,et al. Evidence of a metabolic memory to early-life dietary restriction in male C57BL/6 mice , 2012, Longevity & healthspan.
[50] Dudley Lamming,et al. Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2 , 2012, Front. Gene..
[51] F. Muller,et al. Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS , 2012, Neurobiology of Aging.
[52] Dudley Lamming,et al. mTORC1 in the Paneth cell niche couples intestinal stem cell function to calorie intake , 2012, Nature.
[53] Dudley Lamming,et al. Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.
[54] S. Kliewer,et al. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. , 2012, Genes & development.
[55] Y. Jan,et al. Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity , 2011, Journal of Molecular Medicine.
[56] J. Grande,et al. Effects of Intermittent and Chronic Calorie Restriction on Mammalian Target of Rapamycin (mTOR) and IGF-I Signaling Pathways in Mammary Fat Pad Tissues and Mammary Tumors , 2011, Nutrition and Cancer.
[57] R. de Cabo,et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.
[58] K. Flurkey,et al. Life extension by diet restriction and N-acetyl-L-cysteine in genetically heterogeneous mice. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.
[59] L. Partridge,et al. Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster , 2010, Cell metabolism.
[60] H. Hsu,et al. Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice. , 2009, Basic & clinical pharmacology & toxicology.
[61] B. Kennedy,et al. Ageing: A midlife longevity drug? , 2009, Nature.
[62] Marco Pahor,et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.
[63] V. Monnier,et al. Plasma glucose and the action of calorie restriction on aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[64] C. Álvarez,et al. Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. , 2007, The Journal of endocrinology.
[65] Seung-Jae V. Lee,et al. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans , 2007, Aging cell.
[66] M. Antoch,et al. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. , 2006, Genes & development.
[67] K. Coschigano. Aging-related characteristics of growth hormone receptor/binding protein gene-disrupted mice , 2006, AGE.
[68] E. Ravussin,et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. , 2006, Diabetes care.
[69] Andrzej Bartke,et al. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[70] Matt Kaeberlein,et al. Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients , 2005, Science.
[71] Z. D. Sharp,et al. Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[72] S. Benzer,et al. Regulation of Lifespan in Drosophila by Modulation of Genes in the TOR Signaling Pathway , 2004, Current Biology.
[73] Tibor Vellai,et al. Genetics: Influence of TOR kinase on lifespan in C. elegans , 2003, Nature.
[74] S. Del Prato,et al. Reducing insulin resistance with metformin: the evidence today. , 2003, Diabetes & metabolism.
[75] Wen-Hwa Lee,et al. Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice. , 2003, Carcinogenesis.
[76] Andrzej Bartke,et al. Longevity: Extending the lifespan of long-lived mice , 2001, Nature.
[77] D. Allison,et al. Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr. , 2001, American journal of physiology. Endocrinology and metabolism.
[78] F. Dominici,et al. Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. , 2000, The Journal of endocrinology.
[79] S. Bennett,et al. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[80] B. Hass,et al. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[81] A. Gingras,et al. Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation. , 1996, The EMBO journal.
[82] I. Stansfield,et al. An MBoC Favorite: TOR controls translation initiation and early G1 progression in yeast , 2012, Molecular biology of the cell.
[83] S. Perkins,et al. Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[84] C. McMahan,et al. Dietary restriction alters characteristics of glucose fuel use. , 1992, Journal of gerontology.
[85] L. Groop,et al. Weight loss by very-low-calorie diets: effects on substrate oxidation, energy expenditure, and insulin sensitivity in obese subjects. , 1992, The American journal of clinical nutrition.
[86] C M McCay,et al. The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. , 1935, Nutrition.
[87] D. Harrison,et al. Effects of food restriction on aging: separation of food intake and adiposity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.